Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A meta‐analysis

By Ruben Hernaez, Mariana Lazo, Susanne Bonekamp, I. Kamel, F. Brancati, Eliseo Guallar, J. Clark. Hepatology, 2011

1,498 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Epidemiology, Hepatology

View Paper: https://www.semanticscholar.org/paper/66e660f3542577751795db313a3a03178d3c1c65

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. Terry M. Therneau

In Epidemiology

1. Christopher D. Byrne
2. G. Targher
3. Terry M. Therneau
4. Laurent Castéra
5. A. Berzigotti

In Hepatology

1. Christopher D. Byrne
2. G. Targher
3. Laurent Castéra
4. A. Berzigotti

Citations in the corpus

• Association between Non-invasive Fibrosis Markers and Mortality among Adults with Non-alcoholic Fatty Liver Disease in the United States (2013, methodology): “Although USG may not be as accurate as MRS, its utility in the diagnosis of hepatic steatosis is quite high, as shown in a recent systemic review.(11) The main limitation of USG in the evaluation of patients with NAFLD is that it is unable to distinguish between NAFLD with and without advanced fibro”
• Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss (2022, background): “The sensitivity and the specificity of US are respectively 89 and 93% in detecting increased fibrosis and steatosis [35].”
• A comparison of Cohen’s Kappa and Gwet’s AC1 when calculating inter-rater reliability coefficients: a study conducted with personality disorder samples (2013, background): “Most recently published articles that have assessed inter-rater reliability have used Cohen’s Kappa exclusively [19-26], and a recent review of the current methods used for inter-rater reliability does not even mention AC1 [27].”
• NAFLD: a multisystem disease. (2015, background): “S48 Journal of Hepatology 201 regarding the sensitivity and specificity of ultrasonography to detect liver fat, the reader is referred to the following [10–12]; and for information, regarding the sensitivity and reproducibility of magnetic resonance techniques to assess liver fat [13,14].”
• Easl Clinical Practice Guidelines (Cpgs) On Non-Invasive Tests For Evaluation Of Liver Disease Severity And Prognosis- 2020 Update. (2021, background): “In a large meta-analysis [110] (n=34 studies, 2815 patients with”